Ralimetinib T16721
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38_ MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK _/_ (IC50s: 5.3 and 3.
CAS nr:
862505-00-8
Purity:
98%
Molecular Weight:
420,53
SMILES:
NC1=NC2=CC=C(C3=C(C4=CC=C(F)C=C4)N=C(C(C)(C)C)N3)N=C2N1CC(C)(C)C
Formula:
C24H29FN6
Pathway:
Others
Target:
Others
